APOB and homozygous familial hypercholesterolemia: Relative to baseline levels, LDL-C levels at week 56 were 38% low.These findings imply that lomitapide combined with other LLTs significantlysuppressed LDL-C and Apo B levels in Japanese adult HoFH patients.